Chiasma, Inc. announced the appointment of Anand Varadan as Executive Vice President, Chief Commercial Officer. Mr. Varadan will lead Chiasma’s commercial strategy and operations. Mr. Varadan served as Chiasma’s Chief Commercial Officer until June 2016. He reengaged with the company as a strategic advisor in early 2018 and has been leading MYCAPSSA launch preparations over the last eight months. Previously, Mr. Varadan served as Executive Vice President, Chief Commercial Officer of Karyopharm Therapeutics, Inc., until July 2019 where he built their commercial organization and led preparations for the successful launch of Xpovio for multiple myeloma.